108 research outputs found
Random on-board pixel sampling (ROPS) X-ray Camera
Recent advances in compressed sensing theory and algorithms offer new
possibilities for high-speed X-ray camera design. In many CMOS cameras, each
pixel has an independent on-board circuit that includes an amplifier, noise
rejection, signal shaper, an analog-to-digital converter (ADC), and optional
in-pixel storage. When X-ray images are sparse, i.e., when one of the following
cases is true: (a.) The number of pixels with true X-ray hits is much smaller
than the total number of pixels; (b.) The X-ray information is redundant; or
(c.) Some prior knowledge about the X-ray images exists, sparse sampling may be
allowed. Here we first illustrate the feasibility of random on-board pixel
sampling (ROPS) using an existing set of X-ray images, followed by a discussion
about signal to noise as a function of pixel size. Next, we describe a possible
circuit architecture to achieve random pixel access and in-pixel storage. The
combination of a multilayer architecture, sparse on-chip sampling, and
computational image techniques, is expected to facilitate the development and
applications of high-speed X-ray camera technology.Comment: 9 pages, 6 figures, Presented in 19th iWoRI
Simultaneous X-ray diffraction and phase-contrast imaging for investigating material deformation mechanisms during high-rate loading
Using a high-speed camera and an intensified charge-coupled device (ICCD), a simultaneous X-ray imaging and diffraction technique has been developed for studying dynamic material behaviors during high-rate tensile loading. A Kolsky tension bar has been used to pull samples at 1000 s(−1) and 5000 s(−1) strain-rates for super-elastic equiatomic NiTi and 1100-O series aluminium, respectively. By altering the ICCD gating time, temporal resolutions of 100 ps and 3.37 µs have been achieved in capturing the diffraction patterns of interest, thus equating to single-pulse and 22-pulse X-ray exposure. Furthermore, the sample through-thickness deformation process has been simultaneously imaged via phase-contrast imaging. It is also shown that adequate signal-to-noise ratios are achieved for the detected white-beam diffraction patterns, thereby allowing sufficient information to perform quantitative data analysis diffraction via in-house software (WBXRD_GUI). Of current interest is the ability to evaluate crystal d-spacing, texture evolution and material phase transitions, all of which will be established from experiments performed at the aforementioned elevated strain-rates
Pseudo-unitary symmetry and the Gaussian pseudo-unitary ensemble of random matrices
Employing the currently discussed notion of pseudo-Hermiticity, we define a
pseudo-unitary group. Further, we develop a random matrix theory which is
invariant under such a group and call this ensemble of pseudo-Hermitian random
matrices as the pseudo-unitary ensemble. We obtain exact results for the
nearest-neighbour level spacing distribution for (2 X 2) PT-symmetric
Hamiltonian matrices which has a novel form, s log (1/s) near zero spacing.
This shows a level repulsion in marked distinction with an algebraic form in
the Wigner surmise. We believe that this paves way for a description of varied
phenomena in two-dimensional statistical mechanics, quantum chromodynamics, and
so on.Comment: 9 pages, 2 figures, LaTeX, submitted to the Physical Review Letters
on August 20, 200
Supersymmetric Many-particle Quantum Systems with Inverse-square Interactions
The development in the study of supersymmetric many-particle quantum systems
with inverse-square interactions is reviewed. The main emphasis is on quantum
systems with dynamical OSp(2|2) supersymmetry. Several results related to
exactly solved supersymmetric rational Calogero model, including shape
invariance, equivalence to a system of free superoscillators and non-uniqueness
in the construction of the Hamiltonian, are presented in some detail. This
review also includes a formulation of pseudo-hermitian supersymmetric quantum
systems with a special emphasis on rational Calogero model. There are quite a
few number of many-particle quantum systems with inverse-square interactions
which are not exactly solved for a complete set of states in spite of the
construction of infinitely many exact eigen functions and eigenvalues. The
Calogero-Marchioro model with dynamical SU(1,1|2) supersymmetry and a quantum
system related to short-range Dyson model belong to this class and certain
aspects of these models are reviewed. Several other related and important
developments are briefly summarized.Comment: LateX, 65 pages, Added Acknowledgment, Discussions and References,
Version to appear in Jouranl of Physics A: Mathematical and Theoretical
(Commissioned Topical Review Article
Quantum chaos, random matrix theory, and statistical mechanics in two dimensions - a unified approach
We present a theory where the statistical mechanics for dilute ideal gases
can be derived from random matrix approach. We show the connection of this
approach with Srednicki approach which connects Berry conjecture with
statistical mechanics. We further establish a link between Berry conjecture and
random matrix theory, thus providing a unified edifice for quantum chaos,
random matrix theory, and statistical mechanics. In the course of arguing for
these connections, we observe sum rules associated with the outstanding
counting problem in the theory of braid groups. We are able to show that the
presented approach leads to the second law of thermodynamics.Comment: 23 pages, TeX typ
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain
<p>Abstract</p> <p>Background</p> <p>Opioid analgesics have proven efficacy in the short-term management of chronic cancer pain, but data on their long-term use is more limited. OROS<sup>® </sup>hydromorphone is a controlled-release formulation of oral hydromorphone that may be particularly well suited to long-term management of chronic cancer pain because it provides stable plasma concentrations and consistent analgesia with convenient once-daily dosing. The objective of this study (DO-118X) was to characterise the pain control achieved with long-term repeated dosing of OROS<sup>® </sup>hydromorphone in patients with chronic cancer pain.</p> <p>Methods</p> <p>In this multicentre, phase III, open-label, single treatment, 1-year extension study, OROS<sup>® </sup>hydromorphone was administered to 68 patients with moderate-to-severe chronic cancer pain, who had successfully completed a short-term equivalence study, and whose pain was controlled with a stable dose of medication (≥ 8 mg OROS<sup>® </sup>hydromorphone or equivalent controlled-release morphine). Patients were started on the dose of OROS<sup>® </sup>hydromorphone equivalent to the opioid dose on which they achieved dose-stable pain control in the equivalence study; dose adjustments were made as necessary and breakthrough pain medication was permitted. Efficacy was assessed with the Brief Pain Inventory (BPI) and patient and investigator global evaluations of treatment effectiveness. No formal statistical analysis was done.</p> <p>Results</p> <p>The mean (standard deviation) duration of exposure to study medication was 139 (129.9) days and the mean (standard deviation) average daily consumption of OROS<sup>® </sup>hydromorphone was 43.7 (28.14) mg/day. All scores were maintained at a mild to moderate severity throughout the study; however, BPI scores for pain at its worst, pain at its least, pain on average, pain right now, and pain relief were slightly worsened at end point compared with baseline. Mean BPI pain interference with daily activities and patient and investigator global evaluation scores also remained generally stable. Treatment effectiveness was rated as fair to good throughout the study. The most frequently reported adverse events were nausea (n = 24, 35.3%), constipation (n = 22, 32.4%), and vomiting (n = 15, 22.1%).</p> <p>Conclusion</p> <p>The results of this extension study suggest that long-term repeated dosing with once-daily OROS<sup>® </sup>hydromorphone can be beneficial in the continuing management of persistent, moderate-to-severe cancer pain.</p
- …